Wait, we have a special offer for you! ✋

Get your exclusive discount now

Use FY25SAVE to get flat 20% off on the report No, I'd pay the full price

Terms & Conditions : This coupon is vaild exclusively for Global Market Reports 2025 and can be used Until March 31 , 2025 .

Global Patient Risk Stratification Market Report 2025

Patient Risk Stratification Global Market Report 2025 – By Type (Predictive Risk Stratification Model, Retrospective Risk Stratification Model, Prospective Risk Stratification Model, Concurrent Risk Stratification Model), By Component (Software, Services), By Delivery Model (On-Premise, Cloud-Based), By Application (Risk Adjustment, Clinical Workflow, Revenue Cycle Management, Other Applications), By End User (Healthcare Providers, Healthcare Payers, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

Patient Risk Stratification Global Market Report 2025

Report Price : $4490.00 | Pages : | Published : January 2025 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options
Request a Sample
Request For Discount
Customise Your Report
Item added to cart!
Request For Proposal
Request For Regional Data
FAQs

Need assistance or more information before the purchase?

Enquire Before Buying
Patient Risk Stratification Global Market Report 2025

Proud Members Of

checkslacipN checkaoirsN checkscipN
Description Table Of Contents Tables & Figures Market Insights Related Reports

Patient Risk Stratification Market Definition

Patient risk stratification is the process of assessing and categorizing patients based on their risk of experiencing adverse health outcomes. It is used to identify high-risk patients for targeted interventions, optimize resource allocation, facilitate preventive care, improve care coordination, enhance patient outcomes, reduce costs, and support population health management.

The main types of patient risk stratification are predictive risk stratification models, retrospective risk stratification models, prospective risk stratification models, and concurrent risk stratification models. Predictive risk stratification models use historical and current patient data to forecast future health outcomes and identify individuals at high risk of developing specific conditions or complications. The components are software and services, and the delivery models include on-premise and cloud-based. The various applications are risk adjustment, clinical workflow, revenue cycle management, and others, and they are used by various end users such as healthcare providers, healthcare payers, and others.

Patient Risk Stratification Market Segmentation

The patient risk stratification market covered in this report is segmented –

1) By Type: Predictive Risk Stratification Model, Retrospective Risk Stratification Model, Prospective Risk Stratification Model, Concurrent Risk Stratification Model

2) By Component: Software, Services

3) By Delivery Model: On-Premise, Cloud-Based

4) By Application: Risk Adjustment, Clinical Workflow, Revenue Cycle Management, Other Applications

5) By End User: Healthcare Providers, Healthcare Payers, Other End Users

Subsegments:

1) By Predictive Risk Stratification Model: Machine Learning-Based Predictive Models, Statistical Predictive Models, AI-Powered Predictive Models

2) By Retrospective Risk Stratification Model: Historical Data-Based Risk Models, Data Mining Retrospective Models

3) By Prospective Risk Stratification Model: Longitudinal Cohort-Based Models, Real-Time Risk Assessment Models

4) By Concurrent Risk Stratification Model: In-Hospital Risk Assessment Models, Real-Time Clinical Decision Support Models

Patient Risk Stratification Market Size and growth rate 2025 to 2029: Graph

Patient Risk Stratification Market Size 2025 And Growth Rate

The patient risk stratification market size has grown exponentially in recent years. It will grow from $2.15 billion in 2024 to $2.82 billion in 2025 at a compound annual growth rate (CAGR) of 31.3%. The growth in the historic period can be attributed to increased adoption of digitization, increased risk, rising geriatric population, rising frequency of medical errors, and rising adoption of electronic health records (EHR).

Patient Risk Stratification Market Growth Forecast

The patient risk stratification market size is expected to see exponential growth in the next few years. It will grow to $8.30 billion in 2029 at a compound annual growth rate (CAGR) of 31.0%. The growth in the forecast period can be attributed to rising middle-class and health insurance, increasing prevalence of chronic diseases, growing adoption of predictive analytics, growing emphasis on social determinants of health (SDOH), and expanding use of technology. Major trends in the forecast period include advancements in analytics, artificial intelligence (AI), machine learning, technological advancements, innovative tools, technological advancements in healthcare, wearable technology, and remote monitoring.

Book your 30 minutes free consultation with our research experts

Contact Us

Patient Risk Stratification Market Driver: Impact Of Rising Chronic Disease Burden On The Growth Of The Patient Risk Stratification Market

The growing burden of chronic diseases is expected to propel the growth of the patient risk stratification market going forward. Chronic diseases are long-lasting health conditions that persist for extended periods, typically three months or longer. The growing burden of chronic diseases can be attributed to an aging population, unhealthy lifestyles, urbanization, environmental factors, limited healthcare access, economic disparities, and increased stress levels. Patient risk stratification helps identify individuals at different risk levels for chronic diseases, allowing for personalized care, early intervention, better resource allocation, and improved health outcomes. For instance, in January 2023, according to the National Center for Biotechnology Information (NCBI), a US-based National Library of Medicine, the number of individuals aged 50 and older with at least one chronic illness is projected to increase by 99.5%, from 71.522 million in 2020 to 142.66 million by 2050. Furthermore, in September 2022, according to the World Health Organization (WHO) 2022 Highlights, a Switzerland-based intergovernmental health organization, chronic diseases accounted for 74% of all deaths globally, with 41 million deaths annually. Cardiovascular diseases cause 17.9 million deaths, cancer causes 9.3 million, chronic respiratory diseases cause 4.1 million, and diabetes causes 2.0 million deaths. Therefore, the growing burden of chronic diseases drives the patient risk stratification market.

Global Patient Risk Stratification Market Major Players

Major companies operating in the patient risk stratification market are Bristol-Myers Squibb, Thermo Fisher Scientific Inc., Abbott Laboratories, Sales Force Inc., Medtronic plc, Siemens Healthineers AG, Koninklijke Philips N.V., GE HealthCare Technologies Inc., Adobe Inc., Persistent Systems, NextGen Healthcare Inc., Health Catalyst, Freenome, Strive Health, Medeanalytics Inc., American Academy of Family Physicians, Lightbeam Health Solutions, Graphnet Health Ltd., Innova Medical Group Inc., Equipo Health Inc., Epic Systems Corporation

Global Patient Risk Stratification Market Trend: Technological Advancements In AI-Driven Disease Screening For Enhancing Patient Risk Stratification And Care

Major companies operating in the patient risk stratification market are focusing on technological advancements in healthcare, such as artificial intelligence (AI) in disease screening, to improve early detection, enhance patient outcomes, and reduce healthcare costs by enabling more accurate risk assessments and personalized treatment plans. AI in disease screening utilizes sophisticated algorithms and machine learning to examine medical data, enabling early disease detection and improving diagnostic accuracy by quickly analyzing large amounts of information. For instance, in May 2024, WELL Health Technologies Corporation, a Canada-based healthcare company, and its investee company HEALWELL AI, a Canada-based healthcare company focused on AI and data science for preventative care, launched WELL AI Decision Support (WAIDS). It is aimed at rare diseases and now includes screening for chronic conditions such as kidney disease, hypertension, and diabetes. It can detect over 100 diseases and provide risk stratification, helping clinicians identify care gaps and access actionable data at the point of care.

Patient Risk Stratification Market Merger And Acquisition: Acquisition To Enhance Patient Outcomes And Healthcare Efficiency

In December 2023, Healthcare Outcomes Performance Company (HOPCo), a US-based provider of healthcare performance improvement solutions focusing on data analytics and patient outcomes, acquired MyACTome for an undisclosed amount. With this acquisition, HOPCo aims to improve patient outcomes and enhance the efficiency of healthcare delivery. MyACTome is a US-based company smartphone-based platform that specializes in assessing fall risk and frailty, playing a crucial role in patient risk stratification.

Regional Outlook For The Global Patient Risk Stratification Market

North America was the largest region in the patient risk stratification market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the patient risk stratification market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the patient risk stratification market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Patient Risk Stratification Market?

The patient risk stratification market includes revenues earned by entities by risk assessment and stratification services, telehealth services, medication management services, chronic disease risk assessment services, and genomic risk stratification services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Patient Risk Stratification Industry?

The patient risk stratification market research report is one of a series of new reports from The Business Research Company that provides patient risk stratification market statistics, including patient risk stratification industry global market size, regional shares, competitors with a patient risk stratification market share, detailed patient risk stratification market segments, market trends and opportunities, and any further data you may need to thrive in the patient risk stratification industry. This patient risk stratification market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Patient Risk Stratification Market Report Forecast Analysis
Report AttributeDetails
Market Size Value In 2025 2.82 billion
Revenue Forecast In 2034 $8.30 billion
Growth Rate CAGR of 31.0% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered The patient risk stratification market covered in this report is segmented –
1) By Type: Predictive Risk Stratification Model, Retrospective Risk Stratification Model, Prospective Risk Stratification Model, Concurrent Risk Stratification Model
2) By Component: Software, Services
3) By Delivery Model: On-Premise, Cloud-Based
4) By Application: Risk Adjustment, Clinical Workflow, Revenue Cycle Management, Other Applications
5) By End User: Healthcare Providers, Healthcare Payers, Other End Users Subsegments:
1) By Predictive Risk Stratification Model: Machine Learning-Based Predictive Models, Statistical Predictive Models, AI-Powered Predictive Models
2) By Retrospective Risk Stratification Model: Historical Data-Based Risk Models, Data Mining Retrospective Models
3) By Prospective Risk Stratification Model: Longitudinal Cohort-Based Models, Real-Time Risk Assessment Models
4) By Concurrent Risk Stratification Model: In-Hospital Risk Assessment Models, Real-Time Clinical Decision Support Models
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Bristol-Myers Squibb, Thermo Fisher Scientific Inc., Abbott Laboratories, Sales Force Inc., Medtronic plc, Siemens Healthineers AG, Koninklijke Philips N.V., GE HealthCare Technologies Inc., Adobe Inc., Persistent Systems, NextGen Healthcare Inc., Health Catalyst, Freenome, Strive Health, Medeanalytics Inc., American Academy of Family Physicians, Lightbeam Health Solutions, Graphnet Health Ltd., Innova Medical Group Inc., Equipo Health Inc., Epic Systems Corporation
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Patient Risk Stratification Market Characteristics

    3. Patient Risk Stratification Market Trends And Strategies

    4. Patient Risk Stratification Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

    5. Global Patient Risk Stratification Growth Analysis And Strategic Analysis Framework

    5.1. Global Patient Risk Stratification PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

    5.2. Analysis Of End Use Industries

    5.3. Global Patient Risk Stratification Market Growth Rate Analysis

    5.4. Global Patient Risk Stratification Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

    5.5. Global Patient Risk Stratification Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

    5.6. Global Patient Risk Stratification Total Addressable Market (TAM)

    6. Patient Risk Stratification Market Segmentation

    6.1. Global Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Predictive Risk Stratification Model

    Retrospective Risk Stratification Model

    Prospective Risk Stratification Model

    Concurrent Risk Stratification Model

    6.2. Global Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Software

    Services

    6.3. Global Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    On-Premise

    Cloud-Based

    6.4. Global Patient Risk Stratification Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Risk Adjustment

    Clinical Workflow

    Revenue Cycle Management

    Other Applications

    6.5. Global Patient Risk Stratification Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Healthcare Providers

    Healthcare Payers

    Other End Users

    6.6. Global Patient Risk Stratification Market, Sub-Segmentation Of Predictive Risk Stratification Model, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Machine Learning-Based Predictive Models

    Statistical Predictive Models

    AI-Powered Predictive Models

    6.7. Global Patient Risk Stratification Market, Sub-Segmentation Of Retrospective Risk Stratification Model, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Historical Data-Based Risk Models

    Data Mining Retrospective Models

    6.8. Global Patient Risk Stratification Market, Sub-Segmentation Of Prospective Risk Stratification Model, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Longitudinal Cohort-Based Models

    Real-Time Risk Assessment Models

    6.9. Global Patient Risk Stratification Market, Sub-Segmentation Of Concurrent Risk Stratification Model, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    In-Hospital Risk Assessment Models

    Real-Time Clinical Decision Support Models

    7. Patient Risk Stratification Market Regional And Country Analysis

    7.1. Global Patient Risk Stratification Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    7.2. Global Patient Risk Stratification Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8. Asia-Pacific Patient Risk Stratification Market

    8.1. Asia-Pacific Patient Risk Stratification Market Overview

    Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8.3. Asia-Pacific Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8.4. Asia-Pacific Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    9. China Patient Risk Stratification Market

    9.1. China Patient Risk Stratification Market Overview

    9.2. China Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    9.3. China Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    9.4. China Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    10. India Patient Risk Stratification Market

    10.1. India Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    10.2. India Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    10.3. India Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11. Japan Patient Risk Stratification Market

    11.1. Japan Patient Risk Stratification Market Overview

    11.2. Japan Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11.3. Japan Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11.4. Japan Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12. Australia Patient Risk Stratification Market

    12.1. Australia Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12.2. Australia Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12.3. Australia Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13. Indonesia Patient Risk Stratification Market

    13.1. Indonesia Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13.2. Indonesia Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13.3. Indonesia Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14. South Korea Patient Risk Stratification Market

    14.1. South Korea Patient Risk Stratification Market Overview

    14.2. South Korea Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14.3. South Korea Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14.4. South Korea Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15. Western Europe Patient Risk Stratification Market

    15.1. Western Europe Patient Risk Stratification Market Overview

    15.2. Western Europe Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15.3. Western Europe Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15.4. Western Europe Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16. UK Patient Risk Stratification Market

    16.1. UK Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16.2. UK Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16.3. UK Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17. Germany Patient Risk Stratification Market

    17.1. Germany Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17.2. Germany Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17.3. Germany Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18. France Patient Risk Stratification Market

    18.1. France Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18.2. France Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18.3. France Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19. Italy Patient Risk Stratification Market

    19.1. Italy Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19.2. Italy Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19.3. Italy Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20. Spain Patient Risk Stratification Market

    20.1. Spain Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20.2. Spain Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20.3. Spain Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21. Eastern Europe Patient Risk Stratification Market

    21.1. Eastern Europe Patient Risk Stratification Market Overview

    21.2. Eastern Europe Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21.3. Eastern Europe Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21.4. Eastern Europe Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22. Russia Patient Risk Stratification Market

    22.1. Russia Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22.2. Russia Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22.3. Russia Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23. North America Patient Risk Stratification Market

    23.1. North America Patient Risk Stratification Market Overview

    23.2. North America Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23.3. North America Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23.4. North America Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24. USA Patient Risk Stratification Market

    24.1. USA Patient Risk Stratification Market Overview

    24.2. USA Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24.3. USA Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24.4. USA Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25. Canada Patient Risk Stratification Market

    25.1. Canada Patient Risk Stratification Market Overview

    25.2. Canada Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25.3. Canada Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25.4. Canada Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26. South America Patient Risk Stratification Market

    26.1. South America Patient Risk Stratification Market Overview

    26.2. South America Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26.3. South America Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26.4. South America Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27. Brazil Patient Risk Stratification Market

    27.1. Brazil Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27.2. Brazil Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27.3. Brazil Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28. Middle East Patient Risk Stratification Market

    28.1. Middle East Patient Risk Stratification Market Overview

    28.2. Middle East Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28.3. Middle East Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28.4. Middle East Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29. Africa Patient Risk Stratification Market

    29.1. Africa Patient Risk Stratification Market Overview

    29.2. Africa Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29.3. Africa Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29.4. Africa Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    30. Patient Risk Stratification Market Competitive Landscape And Company Profiles

    30.1. Patient Risk Stratification Market Competitive Landscape

    30.2. Patient Risk Stratification Market Company Profiles

    30.2.1. Bristol-Myers Squibb Overview, Products and Services, Strategy and Financial Analysis

    30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis

    30.2.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis

    30.2.4. Sales Force Inc. Overview, Products and Services, Strategy and Financial Analysis

    30.2.5. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis

    31. Patient Risk Stratification Market Other Major And Innovative Companies

    31.1. Siemens Healthineers AG

    31.2. Koninklijke Philips N.V.

    31.3. GE HealthCare Technologies Inc.

    31.4. Adobe Inc.

    31.5. Persistent Systems

    31.6. NextGen Healthcare Inc.

    31.7. Health Catalyst

    31.8. Freenome

    31.9. Strive Health

    31.10. Medeanalytics Inc.

    31.11. American Academy of Family Physicians

    31.12. Lightbeam Health Solutions

    31.13. Graphnet Health Ltd.

    31.14. Innova Medical Group Inc.

    31.15. Equipo Health Inc.

    32. Global Patient Risk Stratification Market Competitive Benchmarking And Dashboard

    33. Key Mergers And Acquisitions In The Patient Risk Stratification Market

    34. Recent Developments In The Patient Risk Stratification Market

    35. Patient Risk Stratification Market High Potential Countries, Segments and Strategies

    35.1 Patient Risk Stratification Market In 2029 - Countries Offering Most New Opportunities

    35.2 Patient Risk Stratification Market In 2029 - Segments Offering Most New Opportunities

    35.3 Patient Risk Stratification Market In 2029 - Growth Strategies

    35.3.1 Market Trend Based Strategies

    35.3.2 Competitor Strategies

    36. Appendix

    36.1. Abbreviations

    36.2. Currencies

    36.3. Historic And Forecast Inflation Rates

    36.4. Research Inquiries

    36.5. The Business Research Company

    36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Patient Risk Stratification Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Patient Risk Stratification Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Patient Risk Stratification Market, Sub-Segmentation Of Predictive Risk Stratification Model, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Patient Risk Stratification Market, Sub-Segmentation Of Retrospective Risk Stratification Model, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Patient Risk Stratification Market, Sub-Segmentation Of Prospective Risk Stratification Model, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Global Patient Risk Stratification Market, Sub-Segmentation Of Concurrent Risk Stratification Model, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Global Patient Risk Stratification Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Global Patient Risk Stratification Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: Asia-Pacific, Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: Asia-Pacific, Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: Asia-Pacific, Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: China, Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: China, Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: China, Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: India, Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: India, Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: India, Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Japan, Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Japan, Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Japan, Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Australia, Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Australia, Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Australia, Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: Indonesia, Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: Indonesia, Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: Indonesia, Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: South Korea, Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: South Korea, Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: South Korea, Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: Western Europe, Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: Western Europe, Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: Western Europe, Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: UK, Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: UK, Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: UK, Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: Germany, Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: Germany, Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: Germany, Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: France, Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: France, Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: France, Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Italy, Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Italy, Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Italy, Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Spain, Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Spain, Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Spain, Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Eastern Europe, Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Eastern Europe, Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Eastern Europe, Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: Russia, Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: Russia, Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: Russia, Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: North America, Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: North America, Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: North America, Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: USA, Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: USA, Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: USA, Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: Canada, Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: Canada, Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: Canada, Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: South America, Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: South America, Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: South America, Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Brazil, Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Brazil, Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Brazil, Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Middle East, Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Middle East, Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Middle East, Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Africa, Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 78: Africa, Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 79: Africa, Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 80: Bristol-Myers Squibb Financial Performance
  • Table 81: Thermo Fisher Scientific Inc. Financial Performance
  • Table 82: Abbott Laboratories Financial Performance
  • Table 83: Sales Force Inc. Financial Performance
  • Table 84: Medtronic plc Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Patient Risk Stratification Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Patient Risk Stratification Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Patient Risk Stratification Market, Sub-Segmentation Of Predictive Risk Stratification Model, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Patient Risk Stratification Market, Sub-Segmentation Of Retrospective Risk Stratification Model, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Patient Risk Stratification Market, Sub-Segmentation Of Prospective Risk Stratification Model, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Global Patient Risk Stratification Market, Sub-Segmentation Of Concurrent Risk Stratification Model, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Global Patient Risk Stratification Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Global Patient Risk Stratification Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: Asia-Pacific, Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: Asia-Pacific, Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: Asia-Pacific, Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: China, Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: China, Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: China, Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: India, Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: India, Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: India, Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Japan, Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Japan, Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Japan, Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Australia, Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Australia, Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Australia, Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: Indonesia, Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: Indonesia, Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: Indonesia, Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: South Korea, Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: South Korea, Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: South Korea, Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: Western Europe, Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: Western Europe, Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: Western Europe, Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: UK, Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: UK, Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: UK, Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: Germany, Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: Germany, Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: Germany, Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: France, Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: France, Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: France, Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Italy, Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Italy, Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Italy, Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Spain, Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Spain, Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Spain, Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Eastern Europe, Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Eastern Europe, Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Eastern Europe, Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: Russia, Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: Russia, Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: Russia, Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: North America, Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: North America, Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: North America, Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: USA, Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: USA, Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: USA, Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: Canada, Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: Canada, Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: Canada, Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: South America, Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: South America, Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: South America, Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Brazil, Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Brazil, Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Brazil, Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Middle East, Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Middle East, Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Middle East, Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Africa, Patient Risk Stratification Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 78: Africa, Patient Risk Stratification Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 79: Africa, Patient Risk Stratification Market, Segmentation By Delivery Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 80: Bristol-Myers Squibb Financial Performance
  • Figure 81: Thermo Fisher Scientific Inc. Financial Performance
  • Figure 82: Abbott Laboratories Financial Performance
  • Figure 83: Sales Force Inc. Financial Performance
  • Figure 84: Medtronic plc Financial Performance

Forecasting Till 2030: Opportunities And Strategies In The Global Value Based Care Payment Market – Includes Value Based Care Payment Market Analysis

Read More

How Will The Nuclear Medicine Market Grow In 2022?

Read More

What Is The Pediatric Imaging Market Overview In 2022?

Read More

Latest Healthcare Technology Management Market Growth Study 2022-2026 By The Business Research Company

Read More

The Business Research Company offers the medical aesthetics market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the hospital acquired infection control market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the multiplex assays market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the healthcare it consulting market research report 2022 with industry size, share, segments and market growth

Read More

Patient Portal Global Market Report 2025 – By Type (Standalone Patient Portals, Integrated Patient Portals ), By Deployment Mode (On-Premise, Cloud-Based ), By End-Users (Providers, Payers, Pharmacies, Other End-Users (Employer Groups and Government Bodies)) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Patient Safety And Risk Management Software Global Market Report 2025 – By Type (Risk Management And Safety Solutions, Claims Management Solutions, Governance, Risk And Compliance Solutions), By Deployment Mode (Private Cloud, Public Cloud), By End-User (Hospitals, Ambulatory Care Centers, Long-Term Care Centers, Pharmacies, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Patient Registry Software Global Market Report 2025 – By Product (Standalone Software, Integrated Software), By Type of Database (Disease Registries, Health Service Registries, Product Registries ), By Deployment Model (On-Premise Models, Cloud-Based Models), By Functionality (Population Health Management (PHM), Patient Care Management, Health Information Exchange (HIE), Point Of Care, Product Outcome Evaluation, Medical Research And Clinical Studies), By End User (Government Organizations And Third-Party Administrators, Hospitals And Medical Practices, Private Payers, Pharmaceutical, Biotechnology, And Medical Device Companies, Research Centers) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Patient Temperature Monitoring Global Market Report 2025 – By Type( Contact-based Temperature Monitoring Systems, Non-Contact-based Temperature Monitoring System), By Site( Non Invasive Temperature Monitoring, Invasive Temperature Monitoring), By Application( Pyrexia/Fever, Hypothermia, Blood Transfusion, Anesthesia, Other Applications), By End User( Hospital and Surgical Centers, Nursing Facilities, Ambulatory Care Centers, Home Care, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Multi-Parameter Patient Monitoring Equipment Global Market Report 2025 – By Product Type (High-Acuity Monitors, Critical Care Monitors, Magnetic Resonance Imaging (MRI) Compatible Monitors, Perioperative Monitor, Mid-Acuity Monitors, Low-Acuity Monitors), By Application (Cardiology, Neurology, Respiratory, Fetal And Neonatal, Other Applications), By End User (Hospitals, Clinics, Ambulatory Surgical Centers, Home Healthcare) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Patient Positioning Systems Global Market Report 2025 – By Product (Tables, Surgical Tables, Radiolucent Imaging Tables, Examination Tables, Other Products), By Application (Surgery, Diagnostics, Other Application), By End User (Hospitals, Ambulatory Surgery Centers, Diagnostic Laboratories, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Patient Transport Services Global Market Report 2025 – By Transport Vehicle (Ground Ambulance, Air Ambulance, Water Ambulance), By Equipment Type (Advanced Life Support (ALS) Patient Transport Service, Basic Life Support (ALS) Patient Transport Service), By Application (Emergency, Non-Emergency), By End-Users (Hospitals, Medical Centers, Retirement Communities, Hospice Care Facilities, Private Paying Customers, Nursing Care Facilities) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Patient Simulators Global Market Report 2025 – By Type (Childbirth Simulator, Adult Patient Simulator, Infant Simulator, Other Types), By Intensity (High-Fidelity Simulator, Medium-Fidelity Simulator, Low-Fidelity Simulator), By End User (Academic Institutes, Hospitals, Military Organizations, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Frequently Asked Questions

What is the definition of the Patient Risk Stratification market?

Patient risk stratification is the process of assessing and categorizing patients based on their risk of experiencing adverse health outcomes. It is used to identify high-risk patients for targeted interventions, optimize resource allocation, facilitate preventive care, improve care coordination, enhance patient outcomes, reduce costs, and support population health management. For further insights on the Patient Risk Stratification market, request a sample here

How will the Patient Risk Stratification market drivers and restraints affect the market dynamics? What forces will shape the Patient Risk Stratification industry going forward?

The Patient Risk Stratification market major growth driver - Impact Of Rising Chronic Disease Burden On The Growth Of The Patient Risk Stratification Market. For further insights on the Patient Risk Stratification market, request a sample here

What is the forecast market size or the forecast market value of the Patient Risk Stratification market?

The Patient Risk Stratification market size has grown strongly in recent years. The patient risk stratification market size has grown exponentially in recent years. It will grow from $2.15 billion in 2024 to $2.82 billion in 2025 at a compound annual growth rate (CAGR) of 31.3%. The growth in the historic period can be attributed to increased adoption of digitization, increased risk, rising geriatric population, rising frequency of medical errors, and rising adoption of electronic health records (EHR). The patient risk stratification market size is expected to see exponential growth in the next few years. It will grow to $8.30 billion in 2029 at a compound annual growth rate (CAGR) of 31.0%. The growth in the forecast period can be attributed to rising middle-class and health insurance, increasing prevalence of chronic diseases, growing adoption of predictive analytics, growing emphasis on social determinants of health (SDOH), and expanding use of technology. Major trends in the forecast period include advancements in analytics, artificial intelligence (AI), machine learning, technological advancements, innovative tools, technological advancements in healthcare, wearable technology, and remote monitoring. For further insights on the Patient Risk Stratification market, request a sample here

How is the Patient Risk Stratification market segmented?

The patient risk stratification market covered in this report is segmented –
1) By Type: Predictive Risk Stratification Model, Retrospective Risk Stratification Model, Prospective Risk Stratification Model, Concurrent Risk Stratification Model
2) By Component: Software, Services
3) By Delivery Model: On-Premise, Cloud-Based
4) By Application: Risk Adjustment, Clinical Workflow, Revenue Cycle Management, Other Applications
5) By End User: Healthcare Providers, Healthcare Payers, Other End Users Subsegments:
1) By Predictive Risk Stratification Model: Machine Learning-Based Predictive Models, Statistical Predictive Models, AI-Powered Predictive Models
2) By Retrospective Risk Stratification Model: Historical Data-Based Risk Models, Data Mining Retrospective Models
3) By Prospective Risk Stratification Model: Longitudinal Cohort-Based Models, Real-Time Risk Assessment Models
4) By Concurrent Risk Stratification Model: In-Hospital Risk Assessment Models, Real-Time Clinical Decision Support Models For further insights on the Patient Risk Stratification market, request a sample here

Which region has the largest share of the Patient Risk Stratification market? What are the other regions covered in the report?

North America was the largest region in the patient risk stratification market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the patient risk stratification market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the Patient Risk Stratification market, request a sample here.

Who are the major players in the Patient Risk Stratification market?

Major companies operating in the patient risk stratification market are Bristol-Myers Squibb, Thermo Fisher Scientific Inc., Abbott Laboratories, Sales Force Inc., Medtronic plc, Siemens Healthineers AG, Koninklijke Philips N.V., GE HealthCare Technologies Inc., Adobe Inc., Persistent Systems, NextGen Healthcare Inc., Health Catalyst, Freenome, Strive Health, Medeanalytics Inc., American Academy of Family Physicians, Lightbeam Health Solutions, Graphnet Health Ltd., Innova Medical Group Inc., Equipo Health Inc., Epic Systems Corporation . For further insights on the Patient Risk Stratification market, request a sample here.

What are the key trends in the Patient Risk Stratification market?

Major trends in the Patient Risk Stratification market include Technological Advancements In AI-Driven Disease Screening For Enhancing Patient Risk Stratification And Care. For further insights on the Patient Risk Stratification market, request a sample here.

What are the major opportunities in the Patient Risk Stratification market? What are the strategies for the Patient Risk Stratification market?

For detailed insights on the major opportunities and strategies in the Patient Risk Stratification market, request a sample here.

How does the Patient Risk Stratification market relate to the overall economy and other similar markets?

For detailed insights on Patient Risk Stratification's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the Patient Risk Stratification industry?

For detailed insights on the mergers and acquisitions in the Patient Risk Stratification industry, request a sample here.

What are the key dynamics influencing the Patient Risk Stratification market growth? SWOT analysis of the Patient Risk Stratification market.

For detailed insights on the key dynamics influencing the Patient Risk Stratification market growth and SWOT analysis of the Patient Risk Stratification industry, request a sample here.